These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6109074)

  • 1. Oestrogen containing oral contraceptives decrease prostacyclin production.
    Ylikorkala O; Puolakka J; Viinikka L
    Lancet; 1981 Jan; 1(8210):42. PubMed ID: 6109074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
    Ylikorkala O; Puolakka J; Viinikka L
    Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oestrogen containing oral contraceptives decrease prostacyclin production (author's transl)].
    Ylikorkala O; Puolakka J; Vinnikka L
    Contracept Fertil Sex (Paris); 1981 Sep; 9(9):547-9. PubMed ID: 12337641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugs.
    Sinzinger H; Klein K; Kaliman J; Silberbauer K; Feigl W
    Pharmacol Res Commun; 1980 Jun; 12(6):515-21. PubMed ID: 6995996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome.
    Hauglustaine D; Vanrenterghem Y; Michielsen OP; van Damme B
    Lancet; 1981 Feb; 1(8215):328-9. PubMed ID: 6109966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
    Mileikowsky GN; Nadler JL; Huey F; Francis R; Roy S
    Am J Obstet Gynecol; 1988 Dec; 159(6):1547-52. PubMed ID: 3061301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.
    Nordøy A; Svensson B; Haycraft D; Hoak JC; Wiebe D
    Scand J Haematol; 1978 Sep; 21(3):177-87. PubMed ID: 362511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
    Smith LF; Whitfield MJ
    Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
    Ylikorkala O; Saarela E; Viinikka L
    J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal smoking and neonatal prostacyclin excretion.
    Viinikka L; Kääpä P; Ylikorkala O
    Dev Pharmacol Ther; 1988; 11(2):88-91. PubMed ID: 3286160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.